TRACON Pharmaceuticals, Inc. (TCON) Stock Analysis
DELISTED
What happened to TRACON Pharmaceuticals, Inc. (TCON) stock?
TRACON Pharmaceuticals, Inc. (TCON) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
TRACON Pharmaceuticals, Inc. (TCON). TRACON Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing cancer therapeutics. Their pipeline includes clinical-stage products like envafolimab and TRC102, targeting solid tumors and lymphomas.
Last analyzed: Mar 16, 2026TRACON Pharmaceuticals, Inc. (TCON) Healthcare & Pipeline Overview
TCON OTC Market Information
TCON trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy TCON shares?
No. TCON stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for TCON elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before TCON stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to TRACON Pharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.